A61P 43/00
Drugs for specific purposes, not provided for in groups a61p1/00-a61p41/00
Official title: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
A61P43/00 (Drugs for specific purposes, not provided for in groups a61p1/00-a61p41/00) appears on 76,805 US grants and 107,604 published applications in this corpus.
Search patents in A61P- Granted patents
- 76,805
- Published applications
- 107,604
- Assignees
- 18,574
- Inventors
- 127,920
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 24 | 0 |
| 1977 | 54 | 0 |
| 1978 | 185 | 0 |
| 1979 | 109 | 0 |
| 1980 | 93 | 0 |
| 1981 | 101 | 0 |
| 1982 | 83 | 0 |
| 1983 | 79 | 0 |
| 1984 | 124 | 0 |
| 1985 | 154 | 0 |
| 1986 | 152 | 0 |
| 1987 | 191 | 0 |
| 1988 | 192 | 0 |
| 1989 | 284 | 0 |
| 1990 | 303 | 0 |
| 1991 | 351 | 0 |
| 1992 | 342 | 0 |
| 1993 | 317 | 0 |
| 1994 | 424 | 0 |
| 1995 | 561 | 0 |
| 1996 | 696 | 0 |
| 1997 | 1016 | 0 |
| 1998 | 1249 | 0 |
| 1999 | 1403 | 0 |
| 2000 | 1499 | 0 |
| 2001 | 1724 | 480 |
| 2002 | 1919 | 2480 |
| 2003 | 1839 | 3961 |
| 2004 | 1435 | 4778 |
| 2005 | 1478 | 5009 |
| 2006 | 2025 | 5096 |
| 2007 | 2126 | 5204 |
| 2008 | 2299 | 6819 |
| 2009 | 2694 | 6855 |
| 2010 | 3667 | 7233 |
| 2011 | 3654 | 6360 |
| 2012 | 4199 | 5712 |
| 2013 | 4555 | 5213 |
| 2014 | 4456 | 5563 |
| 2015 | 4256 | 5415 |
| 2016 | 3755 | 5593 |
| 2017 | 3953 | 5181 |
| 2018 | 3661 | 4112 |
| 2019 | 3255 | 3893 |
| 2020 | 2706 | 3077 |
| 2021 | 2151 | 2387 |
| 2022 | 1516 | 2018 |
| 2023 | 1104 | 1693 |
| 2024 | 1037 | 1492 |
| 2025 | 927 | 1297 |
| 2026 | 428 | 683 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Bioactive agents and methods related thereto6 Oct 2026US 12,753,216 B2Aroa Biosurgery Limited
- Iron supplement compositions and methods of use thereof29 Sep 2026US 12,746,257 B2ThermoLife International, LLC
- DCAS13-mediated therapeutic RNA base editing for in vivo gene therapy29 Sep 2026US 12,746,295 B2University of Massachusetts
- Compositions comprising HDAC inhibitors and retinoids22 Sep 2026US 12,740,953 B2The Regents of the University of California
- Humanized anti-TrkA antibodies and uses thereof22 Sep 2026US 12,742,012 B2Sunshine Lake Pharma Co., Ltd.
- Compositions and methods for treatment of septic shock8 Oct 2026US 2026/0306579 A1Peroxitech Therapeutics, Inc.
- Epigenetic repression protein therapy for rasopathies8 Oct 2026US 2026/0306675 A1Battelle Memorial Institute
- Use of compound in prevention or treatment of radiation-induced brain injury1 Oct 2026US 2026/0294933 A1Guangzhou Cellprotek Pharmaceutical Co., Ltd.
- Beta-caseins in infant milk formula and use for reducing crying episodes in infants1 Oct 2026US 2026/0295006 A1The A2 Milk Company Limited
- Modulation of Dystrophia Myotonica-Protein Kinase (DMPK) Expression1 Oct 2026US 2026/0297587 A1Ionis Pharmaceuticals, Inc.
Most cited
By later US patents
- Drug releasing biodegradable fiber implant1,662US 6,596,296 B1Board of Regents, The University of Texas System · 2003
- Retrograde tissue splitter and method1,605US 5,449,355 AValleylab, Inc. · 1995
- Retrograde tissue splitter and method1,585US 5,797,906 AValleylab, Inc. · 1998
- Immunizing compositions comprising nucleic acids encoding the HIV-1 matrix protein myristate binding site1,449US 7,718,180 B22010
- Sustained release systems of ascorbic acid phosphate1,391US 8,034,363 B2Advanced Technologies and Regenerative Medicine, LLC · 2011